The Management of Interruptions to Radiotherapy in Head and Neck Cancer: An Audit of the Effectiveness of National Guidelines

Clinical Oncology

Volumn 20, Issue 8, 2008, Pages 599-605

  James, N D ^b   Williams, M V ^a,c   Summers, E T ^c   Jones, K ^d   Cottier, B ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL COLLEGE OF RADIOLOGISTS   (United Kingdom)

^d CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Audit; cancer targets; guidelines; head and neck cancer; interruptions to treatment; radiotherapy

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT PLANNING;

DOSE FRACTIONATION; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; MEDICAL AUDIT; PROSPECTIVE STUDIES; RADIATION ONCOLOGY; TIME FACTORS;

EID: 51449099665     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.05.003     Document Type: Article

References (22)

1. Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
2. James N.D., Robertson G., Squire C.J., Forbes H., Jones K., and Cottier B. A national audit of radiotherapy in head and neck cancer. Clin Oncol 15 (2003) 41-46
3. Royal College of Radiologists. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy (1996), Royal College of Radiologists, London
4. Royal College of Radiologists. Guidelines for the management of the unscheduled interruption or prolongation of a radical course of radiotherapy (2002), Royal College of Radiologists, London
5. Joint Council for Clinical Oncology. Reducing delays in cancer treatment: some targets (1993), Royal College of Physicians and Royal College of Radiologists, London
6. Ash D., Barrett A., Hinks A., and Squire C. Re-audit of radiotherapy waiting times 2003. Clin Oncol 16 (2004) 387-394
7. Summers E., and Williams M.V. Re-audit of radiotherapy waiting times, 2005. Royal College of Radiologists. http://www.rcr.ac.uk/docs/general/pdf/RTWT2005report.pdf [accessed 21.08.07]
8. Department of Health. The NHS Cancer Plan. A plan for investment, a plan for reform (2000), Department of Health, London
9. Withers H.R., Maciejewski B., Taylor J.M., and Hliniak A. Accelerated repopulation in head and neck cancer. Front Radiat Ther Oncol 22 (1988) 105-110
10. Bentzen S.M., and Thames H.D. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 22 (1991) 161-166
11. Fowler J.F., and Lindstrom M.J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23 (1992) 457-467
12. Hendry J.H., Roberts S.A., Slevin N.J., Keane T.J., Barton M.B., and Agren-Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 31 (1994) 14-22
13. Robertson C., Robertson A.G., Hendry J.H., et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40 (1998) 319-329
14. Slevin N.J., Hendry J.H., Roberts S.A., and Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 24 (1992) 215-220 1992;25(3):227
15. Maciejewski B., Withers H.R., Taylor J.M., and Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects. Int J Radiat Oncol Biol Phys 18 (1990) 101-111
16. Maciejewski B., Withers H.R., Taylor J.M., and Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 16 (1989) 831-843
17. Maciejewski B., Withers H.R., Taylor J.M., Zajonc-Slowakiewicz A., and Mistur A. Radiotherapy of tonsillar cancer. II. Tumor repopulation and normal tissue tolerance. Nowotwory 39 (1989) 99-110 (in Polish)
18. Skladowski K., Law M.G., Maciejewski B., and Steel G.G. Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol 30 (1994) 109-120
19. Williams M.V., Summers E.T., Drinkwater K., and Barrett A. Radiotherapy dose fractionation, access and waiting in the countries of the UK in 2005. Clin Oncol 19 (2007) 273-286
20. Mackillop W.J. Killing time: the consequences of delays in radiotherapy. Radiother Oncol 84 (2007) 1-4
21. Jensen A.R., Nellemann H.M., and Overgaard J. Tumour progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol 84 (2007) 5-10
22. Huang J., Barbera L., Brouwers M., Browman G., and Mackillop W.J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21 (2003) 555-563